Literature DB >> 9365767

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.

J L Ziegler1, R Newton, E Katongole-Mbidde, S Mbulataiye, K De Cock, H Wabinga, J Mugerwa, E Katabira, H Jaffe, D M Parkin, G Reeves, R Weiss, V Beral.   

Abstract

BACKGROUND: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and with human herpesvirus 8 (HHV-8 or KSHV). Both KS and HIV infection are common in Uganda. We conducted a case-control study of 458 HIV-seropositive. Ugandan adults with KS and 568 HIV-seropositive subjects without KS to examine risk factors for HIV-associated KS.
METHODS: We recruited newly diagnosed adult KS cases from five hospitals in Kampala, Uganda and controls from a large referral clinic for HIV infection at Mulago Hospital. All cases and controls were counselled and tested for HIV and answered an interviewer-administered questionnaire about their home, socio-economic conditions, lifestyle and sexual behaviour before they became ill. Only HIV-seropositive subjects were included in the analysis.
RESULTS: There were 295 males and 163 females with KS and 227 male and 341 female controls. Age distribution was similar but there was a higher proportion of cases (45%) than controls (29%) residing in rural regions of Uganda. KS cases were more likely than controls to have a higher level of education (X2 for trend, 4.8; P = 0.03), to have occupations associated with affluence [chi 2 for heterogeneity, 17.3 on 5 degrees of freedom (df); P = 0.004] and to come from larger settlements [adjusted odds ratio (OR) for settlements of > 1000 versus 10-99 houses, 1.8; 95% confidence interval (CI), 1.1-3.0]. Cases were more likely than controls to have high household income (chi 2 for trend, 32.6; P < 0.001) and other markers of urban or rural wealth such as owning several cows (chi 2 for trend, 9.5; P = 0.002). Cases were more likely to travel away from home (adjusted OR, 1.6; 95% CI, 1.1-2.3) and more likely to have spent increasing time in contact with water (chi 2 for trend, 12.3; P < 0.001). Few indices of sexual behaviour were related to risk of KS, including reported number of sexual partners. Cases were more likely than controls to be married to one rather than several spouses (adjusted OR, 1.6; 95% CI, 1.2-2.2) and to have reported a history of sexually transmitted diseases (STD) (adjusted OR, 1.6; 95% CI, 1.2-2.3).
CONCLUSIONS: Among HIV-infected subjects, KS cases are characterized by better education and greater affluence, compared with controls. Urban address, travel away from home, exposure to water, monogamous marriage and self-reported STD were also more frequent among KS cases than controls. The higher socio-economic status of persons with HIV and KS may be a marker for enhanced exposure to a possibly sexually transmitted agent, or for a delayed exposure to a childhood infection. The risk posed by exposure to water among KS cases requires further study.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Biology; Case Control Studies; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Hiv Infections; Research Methodology; Research Report; Risk Factors; Signs And Symptoms; Studies; Uganda; Viral Diseases

Mesh:

Year:  1997        PMID: 9365767     DOI: 10.1097/00002030-199713000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  16 in total

1.  Multifactorial etiology of Kaposi' sarcoma: a hypothesis.

Authors:  Harry W Haverkos
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

Review 2.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Authors:  Kristen Stolka; Paul Ndom; Jennifer Hemingway-Foday; Jeniffer Iriondo-Perez; Wendell Miley; Nazzarena Labo; Jennifer Stella; Mahamat Abassora; Godfrey Woelk; Robin Ryder; Denise Whitby; Jennifer S Smith
Journal:  Cancer Epidemiol       Date:  2014-03-13       Impact factor: 2.984

4.  Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.

Authors:  D J Speicher; V Ramirez-Amador; D P Dittmer; J Webster-Cyriaque; M T Goodman; A-B Moscicki
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

5.  Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.

Authors:  Alison M Elliott; Denise Whitby; Robert Newton; Katie Wakeham; Emily L Webb; Ismail Sebina; Lawrence Muhangi; Wendell Miley; W Thomas Johnson; Juliet Ndibazza
Journal:  Infect Agent Cancer       Date:  2011-09-30       Impact factor: 2.965

6.  Helicobacter pylori and cancer among adults in Uganda.

Authors:  Robert Newton; John L Ziegler; Delphine Casabonne; Lucy Carpenter; Benjamin D Gold; Marilyn Owens; Valerie Beral; Edward Mbidde; D Maxwell Parkin; Henry Wabinga; Sam Mbulaiteye; Harold Jaffe
Journal:  Infect Agent Cancer       Date:  2006-11-07       Impact factor: 2.965

7.  Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region.

Authors:  F C Kasolo; J Spinks; H Bima; M Bates; U A Gompels
Journal:  J Med Virol       Date:  2007-10       Impact factor: 2.327

8.  Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.

Authors:  Janet M Wojcicki; Rob Newton; Margaret I Urban; Lara Stein; Martin Hale; Moosa Patel; Paul Ruff; Ranjan Sur; Dimitra Bourboulia; Freddy Sitas
Journal:  BMC Infect Dis       Date:  2003-09-12       Impact factor: 3.090

9.  Iron: a target for the management of Kaposi's sarcoma?

Authors:  Thierry Simonart
Journal:  BMC Cancer       Date:  2004-01-15       Impact factor: 4.430

10.  Classic Kaposi's sarcoma in southern Sardinia, Italy.

Authors:  L Atzori; D Fadda; C Ferreli; C Pastorelli; P Iannelli; M Rais; G Faa; P Cocco; N Aste
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.